David McDermott

4.1k total citations · 1 hit paper
3 papers, 3.2k citations indexed

About

David McDermott is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, David McDermott has authored 3 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 1 paper in Surgery. Recurrent topics in David McDermott's work include Renal cell carcinoma treatment (3 papers), Renal and related cancers (2 papers) and Cancer Immunotherapy and Biomarkers (1 paper). David McDermott is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Renal and related cancers (2 papers) and Cancer Immunotherapy and Biomarkers (1 paper). David McDermott collaborates with scholars based in United States, Israel and Poland. David McDermott's co-authors include Robert A. Figlin, Jeffrey A. Sosman, Ingo G.H. Schmidt‐Wolf, Janice Dutcher, О. Л. Барбараш, Laurence Moore, Zoran Kovačević, Anil Kapoor, Erhan Gökmen and Gary R. Hudes and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Clinical Genitourinary Cancer.

In The Last Decade

David McDermott

3 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

2007 2.8k citations Gary R. Hudes, Michael A. Carducci et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David McDermott United States	3	2.3k	2.2k	1.3k	807	301	3	3.2k
Zoran Kovačević Serbia	7	2.1k 0.9×	2.0k 0.9×	1.1k 0.9×	723 0.9×	246 0.8×	31	3.0k
Janice Dutcher United States	9	2.6k 1.1×	2.4k 1.1×	1.4k 1.1×	1.1k 1.3×	276 0.9×	13	3.6k
Erhan Gökmen Türkiye	12	2.2k 1.0×	2.1k 0.9×	1.3k 1.0×	1.0k 1.3×	264 0.9×	56	3.4k
Debasish Roychowdhury United States	12	2.1k 0.9×	1.5k 0.7×	876 0.7×	1.1k 1.3×	284 0.9×	19	3.1k
Norbert Hollaender Switzerland	15	2.5k 1.1×	2.4k 1.1×	1.3k 1.0×	1.0k 1.3×	295 1.0×	29	4.0k
Oleg Gladkov Russia	18	2.3k 1.0×	1.8k 0.8×	1.1k 0.9×	1.8k 2.2×	285 0.9×	65	3.7k
Gladys Urbanowitz United States	8	2.2k 0.9×	1.9k 0.9×	996 0.8×	2.0k 2.5×	575 1.9×	12	4.2k
Ana M. Molina United States	30	2.5k 1.1×	1.7k 0.8×	1.2k 0.9×	1.2k 1.5×	368 1.2×	129	3.5k
James R. Vasselli United States	21	1.2k 0.5×	1.6k 0.7×	1.1k 0.9×	1.2k 1.5×	389 1.3×	37	3.7k
E Solska United States	4	3.9k 1.7×	3.3k 1.5×	2.1k 1.6×	1.9k 2.3×	444 1.5×	7	5.5k

Countries citing papers authored by David McDermott

Since Specialization

Citations

This map shows the geographic impact of David McDermott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David McDermott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David McDermott more than expected).

Fields of papers citing papers by David McDermott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David McDermott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David McDermott. The network helps show where David McDermott may publish in the future.

Co-authorship network of co-authors of David McDermott

This figure shows the co-authorship network connecting the top 25 collaborators of David McDermott. A scholar is included among the top collaborators of David McDermott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David McDermott. David McDermott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Cho, Daniel, Sabina Signoretti, Sandra L. Dabora, et al.. (2007). Potential Histologic and Molecular Predictors of Response to Temsirolimus in Patients with Advanced Renal Cell Carcinoma. Clinical Genitourinary Cancer. 5(6). 379–385. 137 indexed citations

2.

Hudes, Gary R., Michael A. Carducci, Piotr Tomczak, et al.. (2007). Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma. New England Journal of Medicine. 356(22). 2271–2281. 2817 indexed citations breakdown →

3.

Clark, Joseph I., Michael B. Atkins, Walter J. Urba, et al.. (2003). Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial. Journal of Clinical Oncology. 21(16). 3133–3140. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact